4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
7.28
0.18 (2.54%)
At close: Aug 15, 2025, 3:59 PM
7.23
-0.62%
After-hours: Aug 15, 2025, 07:58 PM EDT
4D Molecular Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -54.66M | -47.97M | -49.67M | -43.84M | -34.95M | -32.4M | -32.28M | -10.26M | -29.62M | -28.68M | -27.38M | -25.69M | -28.09M | -26.34M | -25.08M | -22.24M | -7.59M | -16.41M |
Depreciation & Amortization | 1.89M | 1.75M | 1.78M | 1.7M | 1.62M | 1.59M | 1.51M | 1.4M | 1.43M | 1.41M | 1.39M | 879K | 831K | 782K | 1.89M | 382K | 370K | 381K |
Stock-Based Compensation | 4.96M | 6.99M | 7.58M | 6.49M | 6.07M | 5.97M | 5.91M | 4.56M | 4.97M | 4.22M | 4.35M | 4.52M | 4.32M | 3.93M | 3.73M | 3.92M | 3.82M | 2.33M |
Other Working Capital | 1.04M | -6.94M | -5.18M | 8.97M | 98K | -4.22M | 1.75M | 1.73M | 412K | -4.16M | -1.92M | 720K | 2.31M | -1.22M | -5.51M | 962K | -12.99M | -1.71M |
Other Non-Cash Items | -1.15M | -1.35M | -1.84M | 2.05M | -2.3M | 7.72M | 173K | 29K | -205K | -366K | -211K | 252K | 492K | 611K | 738K | 29K | 15K | 116K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -630K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7K | -7K | 94K |
Change in Working Capital | 5.59M | -7.17M | -3.72M | 4.21M | -688K | -3.52M | 664K | 3.1M | 1.36M | -4.49M | -358K | -977K | 2.54M | -2.54M | -3.11M | 2.18M | -12.82M | -1.79M |
Operating Cash Flow | -43.38M | -47.76M | -45.86M | -29.39M | -30.24M | -29.09M | -24.65M | -1.17M | -22.07M | -27.91M | -22.21M | -21.02M | -19.9M | -23.55M | -21.84M | -15.72M | -16.2M | -15.37M |
Capital Expenditures | n/a | -631K | -949K | 1.06M | -349K | -710K | -549K | -405K | -805K | -1.01M | -1.09M | -1.96M | -2.07M | -6.41M | -5.1M | -2.63M | -737K | -642K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 49.08M | n/a | -50.09M | 1.01M | 11.54M | -17.34M | -59.53M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -115.4M | -134.08M | -57.78M | -35.79M | -96.76M | -277.32M | -34.65M | n/a | -5.43M | -14.73M | 100.51M | -187.94M | -6.18M | -59.69M | -32.2M | -136.38M | n/a | n/a |
Sales Maturities Of Investments | 101.62M | 166.66M | 65.79M | 64.87M | 23.57M | 14.78M | 28.51M | 30.39M | 55.52M | 58.87M | -135.19M | 205.28M | 65.72M | 12M | 5M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -2.84M | n/a | -710K | -49.08M | 30.39M | 50.09M | -1.01M | -11.54M | 17.34M | 59.53M | -47.7M | 5M | -136.38M | n/a | -642K |
Investing Cash Flow | -13.85M | 31.95M | 7.06M | 27.3M | -73.54M | -263.26M | -6.68M | 29.98M | 49.29M | 43.13M | -35.78M | 15.37M | 57.47M | -54.11M | -32.29M | -139.01M | -737K | -642K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 332.01M | 567K | 1.56M | 3.11M | 4.76M | 1.58M | 799K | 1.35M | 2.05M | 460K | -50K | 629K | 116.14M | 1.98M | 820K | -847K |
Financial Cash Flow | 862K | n/a | 601K | 568K | 17.25M | 318.83M | 4.76M | 10.56M | 130.52M | 10.99M | 2.05M | 460K | -50K | 629K | 116.14M | 1.98M | 820K | -847K |
Net Cash Flow | -56.37M | -15.81M | -38.2M | -1.52M | -86.53M | -84K | -26.57M | 39.37M | 157.74M | 26.22M | -55.95M | -5.19M | 37.51M | -77.03M | 62.01M | -152.75M | -16.12M | -16.86M |
Free Cash Flow | -43.38M | -47.76M | -46.81M | -28.33M | -30.59M | -29.8M | -25.2M | -1.58M | -22.87M | -28.92M | -23.31M | -22.98M | -21.97M | -29.96M | -26.93M | -18.36M | -16.94M | -16.01M |